Burning Rock Biotech (BNR) Cash from Operations: 2020-2025
Historic Cash from Operations for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $2.3 million.
- Burning Rock Biotech's Cash from Operations rose 114.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.9 million, marking a year-over-year increase of 39.12%. This contributed to the annual value of -$12.6 million for FY2024, which is 64.91% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Cash from Operations is $2.3 million, which was up 124.31% from -$9.5 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Cash from Operations high stood at $2.6 million for Q4 2024, and its period low was -$66.2 million during Q4 2022.
- Its 3-year average for Cash from Operations is -$6.5 million, with a median of -$5.6 million in 2024.
- Per our database at Business Quant, Burning Rock Biotech's Cash from Operations tumbled by 313.05% in 2021 and then soared by 215.74% in 2024.
- Over the past 5 years, Burning Rock Biotech's Cash from Operations (MRQ) stood at -$17.6 million in 2021, then plummeted by 275.71% to -$66.2 million in 2022, then surged by 96.59% to -$2.3 million in 2023, then soared by 215.74% to $2.6 million in 2024, then dropped by 11.80% to $2.3 million in 2025.
- Its Cash from Operations stands at $2.3 million for Q3 2025, versus -$9.5 million for Q2 2025 and -$3.2 million for Q1 2025.